Kraig Biocraft Laboratories (KBLB) 10-Q 5 Nov 21 2021 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 04, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	333-146316
Entity Registrant Name	KRAIG BIOCRAFT LABORATORIES, INC.
Entity Central Index Key	0001413119
Entity Tax Identification Number	83-0459707
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	2723 South State St. Suite 150
Entity Address, City or Town	Ann Arbor
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48104
City Area Code	(734)
Local Phone Number	619-8066
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		907,758,448

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current Assets
Cash	$ 2,693,669	$ 816,907
Prepaid expenses	9,169	2,588
Total Current Assets	2,702,838	819,495
Property and Equipment, net	100,543	89,247
Investment in gold bullions	412,514
Operating lease right-of-use asset, net	114,906	365,025
Security deposit	3,518	3,518
Total Assets	3,334,319	1,277,285
Current Liabilities
Accounts payable and accrued expenses	619,585	600,003
Note payable - related party	1,657,000	1,657,000
Royalty agreement payable - related party	65,292	65,292
Accounts payable and accrued expenses - related party	5,086,258	4,802,985
Operating lease liability, current	33,492	124,909
Loan payable	60,000	60,000
Convertible note payable, net of debt discount of $776,540 and $949,945, respectively	1,523,460	50,505
SBA Paycheck Protection Loan		90,100
Total Current Liabilities	9,045,087	7,450,794
Long Term Liabilities
Loan payable, net of current	110,244	145,244
Operating lease liability, net of current	81,414	254,811
Total Liabilities	9,236,745	7,850,849
Commitments and Contingencies
Stockholders’ Deficit
Preferred stock, value
Common stock, value
Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively	22,000	22,000
Additional paid-in capital	9,814,813	5,833,583
Accumulated Deficit	(41,650,767)	(34,769,183)
Total Stockholders’ Deficit	(5,902,426)	(6,573,564)
Total Liabilities and Stockholders’ Deficit	3,334,319	1,277,285
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value	5,217,800	5,217,800
Common Class A [Member]
Stockholders’ Deficit
Common stock, value	20,693,728	17,122,236
Common Class B [Member]
Stockholders’ Deficit
Common stock, value

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares authorized	Unlimited	Unlimited
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock issuable	1,122,311	1,122,311
Series A Preferred Stock [Member]
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares issued	2	2
Preferred stock, shares outstanding	2	2
Common Class A [Member]
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	897,551,753	854,410,001
Common stock, shares outstanding	897,551,753	854,410,001
Common Class B [Member]
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue
Operating Expenses
General and Administrative	637,611	366,243	1,313,510	3,507,302
Professional Fees	33,179	39,169	259,702	89,643
Officer’s Salary	162,498	161,861	494,090	361,276
Rent - Related Party		3,556	3,683	9,819
Research and Development	39,254	27,626	171,748	65,408
Total Operating Expenses	872,542	598,455	2,242,733	4,033,448
Loss from Operations	(872,542)	(598,455)	(2,242,733)	(4,033,448)
Other Income/(Expenses)
Gain on debt extinguishment (PPP)			90,100
Net change in unrealized depreciation on investment in gold bullion	(37,702)		(37,702)
Interest expense	(188,416)	(94,703)	(518,294)	(279,846)
Amortization of original issue discount	(2,088,487)		(4,172,955)
Total Other Income/(Expenses)	(2,314,605)	(94,703)	(4,638,851)	(279,846)
Net (Loss) before Provision for Income Taxes	(3,187,147)	(693,158)	(6,881,584)	(4,313,294)
Provision for Income Taxes
Net (Loss)	$ (3,187,147)	$ (693,158)	$ (6,881,584)	$ (4,313,294)
Net Income (Loss) Per Share - Basic and Diluted	$ 0	$ 0	$ (0.01)	$ (0.01)
Weighted average number of shares outstanding during the period - Basic and Diluted	879,561,355	851,168,167	865,640,011	846,717,942

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) - USD ($)	Series A Preferred Stocks [Member]	Common Class A Stock [Member]	Common Class B Stock [Member]	Common Stock Class A Shares To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 5,217,800	$ 16,757,079		$ 22,000	$ 2,412,969	$ (29,797,906)	$ (5,388,058)
Beginning Balance, shares at Dec. 31, 2019	2	844,468,378		1,122,311
Warrants issued for services - related parties					2,754,031		2,754,031
Warrants issued for services					50,763		50,763
Exercise of 10,000,000 warrants in exchange for stock		$ 365,157			(365,157)
Exercise of warrants in exchange for stock, shares		9,941,623
Imputed interest - related party					38,981		38,981
Contributed capital - related party					17,495		17,495
Net loss						(4,313,294)	(4,313,294)
Ending balance, value at Sep. 30, 2020	$ 5,217,800	$ 17,122,236		$ 22,000	4,909,082	(34,111,200)	(6,840,082)
Ending Balance, shares at Sep. 30, 2020	2	854,410,001		1,122,311
Beginning balance, value at Jun. 30, 2020	$ 5,217,800	$ 16,757,079		$ 22,000	5,107,560	(33,418,042)	(6,313,603)
Beginning Balance, shares at Jun. 30, 2020	2	844,468,378		1,122,311
Warrants issued for services - related parties					141,620		141,620
Warrants issued for services					8,050		8,050
Exercise of 10,000,000 warrants in exchange for stock		$ 365,157			(365,157)
Exercise of warrants in exchange for stock, shares		9,941,623
Imputed interest - related party					17,009		17,009
Net loss						(693,158)	(693,158)
Ending balance, value at Sep. 30, 2020	$ 5,217,800	$ 17,122,236		$ 22,000	4,909,082	(34,111,200)	(6,840,082)
Ending Balance, shares at Sep. 30, 2020	2	854,410,001		1,122,311
Beginning balance, value at Dec. 31, 2020	$ 5,217,800	$ 17,122,236		$ 22,000	5,833,583	(34,769,183)	(6,573,564)
Beginning Balance, shares at Dec. 31, 2020	2	854,410,001		1,122,311
Warrants issued for services - related parties					505,809		505,809
Warrants issued for services					78,693		78,693
Common stock issued for services		$ 242,100					242,100
Common stock issued for services, shares		3,000,000
Cancellations of warrants					(42,707)		(42,707)
Exercise of 10,000,000 warrants in exchange for stock		$ 470,091			(292,533)		177,558
Exercise of warrants in exchange for stock, shares		3,816,522
Convertible debt conversion into common stock ($0.0744 - $0.1108/Sh)		$ 2,859,301					2,859,301
Convertible debt conversion into common stock ($0.0744 - $0.1108/Sh), shares		36,325,230
Imputed interest - related party					61,968		61,968
Beneficial conversion feature					3,670,000		3,670,000
Net loss						(6,881,584)	(6,881,584)
Ending balance, value at Sep. 30, 2021	$ 5,217,800	$ 20,693,728		$ 22,000	9,814,813	(41,650,767)	(5,902,426)
Ending Balance, shares at Sep. 30, 2021	2	897,551,753		1,122,311
Beginning balance, value at Jun. 30, 2021	$ 5,217,800	$ 18,636,669		$ 22,000	9,572,046	(38,463,620)	(5,015,105)
Beginning Balance, shares at Jun. 30, 2021	2	868,038,875		1,122,311
Warrants issued for services - related parties					166,978		166,978
Warrants issued for services					54,906		54,906
Common stock issued for services		$ 242,100					242,100
Common stock issued for services, shares		3,000,000
Convertible debt conversion into common stock ($0.0744 - $0.1108/Sh)		$ 1,814,959					1,814,959
Convertible debt conversion into common stock ($0.0744 - $0.1108/Sh), shares		26,512,878
Imputed interest - related party					20,883		20,883
Net loss						(3,187,147)	(3,187,147)
Ending balance, value at Sep. 30, 2021	$ 5,217,800	$ 20,693,728		$ 22,000	$ 9,814,813	$ (41,650,767)	$ (5,902,426)
Ending Balance, shares at Sep. 30, 2021	2	897,551,753		1,122,311

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) (Parenthetical) - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Exercise of warrants		3,816,522
Minimum [Member]
Conversion price per share	$ 0.0744	$ 0.0744
Maximum [Member]
Conversion price per share	$ 0.1108	$ 0.1540

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows From Operating Activities:
Net Loss	$ (6,881,584)	$ (4,313,294)
Adjustments to reconcile net loss to net cash used in operations
Depreciation expense	19,304	21,277
Gain on debt extinguishment (PPP)	(90,100)
Net change in unrealized depreciation in gold bullions	37,702
Stock issued for services	242,100
Loss on disposal of fixed assets	49,321
Amortization of debt discount	4,172,955
Imputed interest - related party	61,968	38,981
Fair value of options issued for services		2,804,794
Warrants issued/(cancelled) to consultants	541,795
Changes in operating assets and liabilities:
Decrease (Increase) in prepaid expenses	(6,581)	18,766
Operating lease right-of-use, net	79,290	87,806
Increase in accrued expenses and other payables - related party	283,273	469,268
(Decrease)Increase in accounts payable	178,883	(40,538)
Operating lease liabilities, current	(93,985)	(81,617)
Net Cash Used In Operating Activities	(1,405,659)	(994,557)
Cash Flows From Investing Activities:
Investment in gold bullions	(450,216)
Purchase of Fixed Assets	(79,921)
Net Cash Used In Investing Activities	(530,137)
Cash Flows From Financing Activities:
Proceeds from notes payable - related party		850,000
Proceeds from convertible note payable, net of original issue discount	3,670,000
Principal payments on debt	(35,000)	(45,000)
Proceeds from warrant exercise	177,558
Contributed capital - related party		17,495
Proceeds from SBA Paycheck Protection Loan		90,100
Net Cash Provided by Financing Activities	3,812,558	912,595
Net Increase in Cash	1,876,762	(81,962)
Cash at Beginning of Period	816,907	125,024
Cash at End of Period	2,693,669	43,062
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:
Shares issued in connection with cashless warrants exercise	292,533	365,157
Beneficial conversion feature in connection with convertible debt	3,670,000
Shares issued in connection with convertible note payable	2,859,301
Adoption of lease standard ASC 842	115,390
Shares issued in connection with settlement of accounts payable	159,301
Cancellation and forgiveness of lease - related party	44,419
Cancellation and forgiveness of lease	$ 241,800

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (A) Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. On March 5, 2018, the Company issued a board resolution authorizing investment in a Vietnamese subsidiary and appointing a representative for the subsidiary. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. Foreign Currency The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date. Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Cash For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no Loss Per Share Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For September 30, 2021 and December 31, 2020, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive. The computation of basic and diluted loss per share for September 30, 2021 and 2020 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE September 30, 2021 December 31, 2020 Stock Warrants (Exercise price - $ 0.001 0.25 53,411,461 49,120,917 Stock Options (Exercise price - $ 0.1150 26,802,500 27,340,000 Convertible Debt 19,434,477 - Convertible Preferred Stock 2 2 Total 99,648,440 76,460,919 Research and Development Costs The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation. Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Stock-Based Compensation The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07. Recent Accounting Pronouncements Changes to accounting principles are established by the FASB in the form of ASU’s to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our financial position, results of operations, stockholders’ deficit, cash flows, or presentation thereof. On January 1, 2021, we adopted Accounting Standards Update (ASU) No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (ASU 2020-01), which clarifies the interaction of the accounting for equity securities under Topic 321, the accounting for equity method investments in Topic 323, and the accounting for certain forward contracts and purchased options in Topic 815. The adoption of this new standard did not have a material impact on our condensed consolidated financial statements . In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments, to require financial assets carried at amortized cost to be presented at the net amount expected to be collected based on historical experience, current conditions, and forecasts. Subsequently, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, to clarify that receivables arising from operating leases are within the scope of lease accounting standards. Further, the FASB issued ASU No. 2019-04, ASU No. 2019-05, ASU 2019-10, ASU 2019-11, ASU 2020-02, and ASU 2020-03 to provide additional guidance on the credit losses standard. Adoption of the ASUs is on a modified retrospective basis. We adopted the ASUs on January 1, 2020. The ASUs did not have a material impact on our consolidated financial statements. ASU No. 2016-13 applies to all financial assets including loans, trade receivables and any other financial assets not excluded from the scope that have the contractual right to receive cash. The adoption of this ASU did not have any impact on our financial statements. Equipment The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. In accordance with FASB ASC No. 360, Property, Plant and Equipment, There were no Fair Value of Financial Instruments We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” The three levels of the fair value hierarchy under ASC Topic 820-10 are described below: ● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at September 30, 2021 and 2020. ● Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. ● Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms. SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS September 30, 2021 December 31, 2020 Level 1 – Investment in Gold $ 412,514 $ Level 2 $ - $ - Level 3 $ - $ - Total $ 412,514 $ - The Board of Directors, who serves as the Custodian, is responsible for the safekeeping of gold bullion owned by the Company. Fair value of the gold bullion held by the Company is based on that day’s London Bullion Market Association (“LBMA”) Gold Price PM. “LBMA Gold Price PM” is the price per fine troy ounce of gold, stated in U.S. dollars, determined by ICE Benchmark Administration (“IBA”) following an electronic auction consisting of one or more 30-second rounds starting at 3:00 p.m. (London time), on each day that the London gold market is open for business and published shortly thereafter. SCHEDULE OF GOLD BULLION The following tables summarize activity in gold bullion for the three and nine months ended September 30, 2021: SCHEDULE OF GOLD IN BULLION Three and Nine Months Ended September 30, 2021 Ounces Cost Fair Value Beginning balance - $ - $ - Investment in Gold bullion 239 1,884 450,216 Net change in unrealized depreciation - - (37,702 ) Ending balance 239 $ 1,884 $ 412,514 Revenue Recognition The Company’s revenues have been generated primarily from a contract with the U.S. Government. The Company performed work under a cost-plus-fixed-fee contract. Under the base phase of that contract, the Company produced recombinant spider silk woven into ballistic shootpack panels. Those shootpack panels were delivered to the U.S. Government customer. Under an option period award starting in July 2017 and ending in September 2018, to that original contract, the Company worked to develop new recombinant silks. Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the three and nine months ended September 30, 2021 and 2020, the Company recognized $ 0 0 On January 25, 2021, the Company signed an amendment to a strategic partnership agreement with Kings Group for and exclusive sales agreement for up to $40 million. On April 8, 2021, the Company and Kings Group formed Spydasilk Enterprises Pte. Ltd., a Singapore company, to formalize this partnership. Concentration of Credit Risk The Company at times has cash in banks in excess of FDIC insurance limits. At September 30, 2021 and December 31, 2020, the Company had approximately $ 2,344,000 500,000 For the nine months ended September 30, 2021 and 2020, the Company booked $0 and $0 for doubtful accounts. Original Issue Discount For certain notes issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded as a debt discount, reducing the face amount of the note, and is amortized to amortization of original issue discount in the consolidated statements of operations over the life of the debt. Debt Issue Cost Debt issuance cost paid to lenders, or third parties are recorded as debt discounts and amortized to interest expense in the consolidated statements of operations, over the life of the underlying debt instrument. Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The discount is amortized to interest expense over the life of the debt.

GOING CONCERN

GOING CONCERN	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 GOING CONCERN As reflected in the accompanying condensed unaudited financial statements, the Company has a working capital deficiency of $ 6,342,249 5,902,426 1,405,659 Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

EQUIPMENT

EQUIPMENT	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
EQUIPMENT	NOTE 3 EQUIPMENT At September 30, 2021 and December 31, 2020, property and equipment, net, is as follows: SCHEDULE OF PROPERTY AND EQUIPMENT September 30, 2021 December 31, 2020 Automobile $ 41,805 $ 41,805 Laboratory Equipment 101,656 96,536 Office Equipment 7,260 7,260 Leasehold Improvements 82,742 85,389 Less: Accumulated Depreciation (132,920 ) (141,743 ) Total Property and Equipment, net $ 100,543 $ 89,247 Depreciation expense for the nine months ended September 30, 2021 and 2020, was $ 19,304 21,277 Depreciation expense for the three months ended September 30, 2021 and 2020, was $ 5,858 8,159 During the three and nine months ended September 30, 2021 and 2020, the Company recorded a loss on disposal of fixed assets of $ 49,321 0

RIGHT TO USE ASSETS AND LEASE L

RIGHT TO USE ASSETS AND LEASE LIABILITITY	9 Months Ended
	Sep. 30, 2021
Right To Use Assets And Lease Liabilitity
RIGHT TO USE ASSETS AND LEASE LIABILITITY	NOTE 4 - RIGHT TO USE ASSETS AND LEASE LIABILITITY Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $ 2,508 On January 23, 2017 the Company signed an 8 year property lease with the Company’s President for land in Texas where the Company grows its mulberry. The Company pays a monthly rent of $ 960 3,683 6,263 44,419 On September 5, 2019, we signed a two 5,000 42,000 44,800 42,000 44,800 79,862 79,862 On May 9, 2019 the Company signed a 5 4,560.57 45,150 5 241,800 On July 1, 2021, the Company signed a 5 6,000 8,645 Right to use assets is summarized below: SCHEDULE OF RIGHT USE OF ASSETS September 30, 2021 Right to use assets, net 79,862 Right to use assets, net 35,044 Total $ 114,906 During the nine months ended September 30, 2021, the Company recorded $ 87,874 Lease liability is summarized below: SCHEDULE OF LEASE LIABILITY September 30, 2021 Operating lease liability, net 79,862 Operating lease liability, net 35,044 Total 114,906 Less: short term portion (33,492 ) Long term position $ 81,414 Lease expense for the nine months ended September 30, 2021 was comprised of the following: SCHEDULE OF LEASE COST Operating lease expense $ 34,786 Operating lease expense $ 53,673 Operating lease expense – related party $ 3,683

ACCRUED INTEREST _ RELATED PART

ACCRUED INTEREST – RELATED PARTY	9 Months Ended
	Sep. 30, 2021
Accrued Interest Related Party
ACCRUED INTEREST – RELATED PARTY	NOTE 5 ACCRUED INTEREST – RELATED PARTY On June 6, 2016, the Company received a $ 50,000 30,000 100,000 15,000 20,000 15,000 15,000 20,000 26,000 11,000 20,000 3,000 30,000 30,000 20,000 20,000 17,000 100,000 100,000 100,000 100,000 100,000 100,000 150,000 100,000 100,000 100,000 30,000 30,000 35,000 70,000 3 1,657,000 1,657,000 61,968 40,138 38,981 24,485

NOTE PAYABLE

NOTE PAYABLE	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
NOTE PAYABLE	NOTE 6 NOTE PAYABLE On March 1, 2019, the Company entered into an unsecured promissory note with Notre Dame - an unrelated party in the amount of $ 265,244 10 35,000 1. $ 1,000 2. $ 2,000 3. $ 5,000 4. Final payment of all remaining balance, in the amount of $ 180,224 On July 8, 2021, the Company entered into an amendment to the March 1, 2019 agreement. As of the date of the amendment, the remaining outstanding balance is $ 180,244 1. $ 5,000 2. Final payment of the remaining balance in the amount of $ 115,244 57,622 57,622 On April 16, 2020, the Company, was granted a loan (the “Loan”) from The Huntington National Bank, in the aggregate amount of $ 90,100 April 16, 2020 1 100 90,100

CONVERTIBLE NOTES

CONVERTIBLE NOTES	9 Months Ended
	Sep. 30, 2021
Convertible Notes
CONVERTIBLE NOTES	NOTE 7 CONVERTIBLE NOTES The Company issued a $ 1,000,000 January 11, 2022 10 5 50,000 950,000 The note contains a discount to market feature, whereby, the lender can purchase stock at 90% of the lowest trading price for a period of ten (10) days preceding the conversion date. Additionally, the Company issued 3,125,000 5 2,599,066 SCHEDULE OF FAIR VALUE WARRANTS Stock Price $ 0.14 Exercise price $ 0.16 Expected term (in years) 5 Expected volatility 60.64 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.10 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. Pursuant to ASC 470, the Company will record a beneficial conversion feature (“BCF”) based upon the relative fair value of the conversion feature within the convertible note and the related warrants. The BCF cannot exceed the face amount of the note, therefore, the discount for this note is $ 1,000,000 The Company also paid $ 86,000 On March 25, 2021, the Company entered into one year, unsecured, convertible note in the aggregate principal amount of $ 4,000,000 500,000 March 25, 2022 10 The note contains a discount to market feature, whereby, the lender can purchase stock at 80% of the lowest trading price for a period of ten (10) days preceding the conversion date. 500,000 3,000,000 Additionally, the Company issued 8,000,000 5 3,359,716 Stock Price $ 0.15 Exercise price $ 0.25 Expected term (in years) 5 Expected volatility 100.76 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.07 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. Pursuant to ASC 470, the Company will record a beneficial conversion feature (“BCF”) based upon the relative fair value of the conversion feature within the convertible note and the related warrants. The BCF cannot exceed the face amount of the note, therefore, the discount for this note is $ 3,670,000 The Company also paid $ 330,000 On April 23, 2021, the Company issued 836,574 100,000 1,644 On April 26, 2021, the Company issued 2,063,391 250,000 3,178 On April 30, 2021, the Company issued 2,058,686 250,000 3,630 On June 7, 2021, the Company issued 2,431,506 200,000 25,644 On June 23, 2021, the Company issued 2,422,195 200,000 10,247 On July 6, 2021, the Company issued 2,343,919 200,000 7,671 On July 20, 2021, the Company issued 1,664,823 100,000 60,822 On July 29, 2021, the Company issued 3,101,546 200,000 11,836 On August 16, 2021, the Company issued 2,277,273 150,000 6,904 On August 23, 2021, the Company issued 3,454,203 200,000 11,397 On August 30, 2021, the Company issued 2,284,808 150,000 3,082 On September 8, 2021, the Company issued 4,311,269 250,000 6,521 On September 14, 2021, the Company issued 2,936,668 200,000 2,630 On September 20, 2021, the Company issued 4,138,369 250,000 4,095 The following represents a summary of the Company’s convertible debt at September 30, 2021: SUMMARY OF CONVERTIBLE DEBT Convertible Note Payable Amounts In-Default Balance – December 31, 2020 50,505 - Proceeds – net 4,000,000 - Debt discount recorded (4,000,000 ) - Conversion of debt into common shares (2,700,000 ) Amortization of debt discount 4,172,955 - Balance – September 30, 2021 $ 1,523,460 $ - Accrued Interest Payable Amounts In-Default Balance – December 31, 2020 5,479 - Interest Expense September 30, 2021 201,507 - Interest conversion into common shares (167,274 ) Balance – September 30, 2021 $ 39,712 $ -

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 8 STOCKHOLDERS’ DEFICIT (A) Common Stock Issued for Cash On March 9, 2019, the Company entered into a purchase agreement with one investor (the “Purchase Agreement”). Pursuant to the Purchase Agreement, the Company issued the investor 14,797,278 0.06758 1,000,000 14,797,278 14,797,278 0.06 7,398,639 0.08 ● ½ of all $ 0.06 March 8, 2021 ● ½ of all $ 0.06 March 8, 2022 ● ½ of all $ 0.08 March 8, 2022 ● ½ of all $ 0.08 March 8, 2023 On March 2, 2021, the Company determined to amend and extend the expiration of the warrants expiring on March 8, 2021 as follows: ● 1,479,728 0.06 March 8, 2021 ● 1,479,728 0.06 May 8, 2021 ● 1,479,728 0.06 July 8, 2021 ● 1,479,728 0.06 September 8, 2021 ● 1,479,727 0.06 November 8, 2021 On March 2, 2021, the Company issued 1,479,728 1,479,728 88,784 On May 4, 2021, the Company issued 1,479,728 1,479,728 88,784 (B) Common Stock Issued for Services Shares issued for services as mentioned below were valued at the closing price of the stock on the date of grant. On September 3, 2021, the Company issued 3,000,000 242,100 0.0807 (C) Common Stock Warrants and Options On March 5, 2021, the Company issued 786,280 2,000,000 On March 2, 2021, the Company issued 1,479,728 1,479,728 88,784 On May 4, 2021, the Company issued 1,479,728 1,479,728 88,784 On February 24, 2021, the Company issued 70,786 200,000 On July 30, 2020, the Company issued 9,941,623 10,000,000 SCHEDULE OF OPTION ASSUMPTION On July 8, 2021, the Company issued a 4-year option to purchase 500,000 0.116 46,890 500,000 Expected dividends 0 % Expected volatility 130.18 % Expected term 4 Risk free interest rate 0.37 % Expected forfeitures 0 % On July 8, 2021, the Company extended the expiration date of the warrant issued on February 9, 2018, to July 8, 2025. During the nine months ended September 30, 2021, the Company recorded an additional $ 100,941 Expected dividends 0 % Expected volatility 130.18 % Expected term 4 Risk free interest rate 0.37 % Expected forfeitures 0 % On April 27, 2021, the Company extended the expiration date of the warrant issued on October 2, 2016 to October 1, 2026. During the nine months ended September 30, 2021 the Company recorded an additional $ 217,715 Expected dividends 0 % Expected volatility 158.54 % Expected term 3 Risk free interest rate 1.37 % Expected forfeitures 0 % On February 2, 2021, the Company extended the expiration date of the warrant to May 29, 2026. During the nine months ended September 30, 2021 the Company recorded an additional $ 85 Expected dividends 0 % Expected volatility 112 % Expected term 5 Risk free interest rate 0.18 % Expected forfeitures 0 % On January 1, 2016, the Company issued 3-year warrant to purchase 6,000,000 0.001 142,526 85 Expected dividends 0 % Expected volatility 112 % Expected term 5 Risk free interest rate 0.18 % Expected forfeitures 0 % On January 25, 2021, the Company issued a 7-year option to purchase 2,500,000 0.134 310,165 Options vest 33.3% on the year one anniversary of the grant date, 33.3% will vest on the second anniversary, and 33.3% will vest on the third year anniversary as long as the employee remains with the Company at the end of each successive year for three years 65,194 Expected dividends 0 % Expected volatility 133.22 % Expected term 7 Risk free interest rate 1.46 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 10-year option to purchase 6,000,000 0.115 626,047 Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030 77,988 Expected dividends 0 % Expected volatility 125.19 % Expected term 3 Risk free interest rate 1.50 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 7-year option to purchase 1,340,000 0.115 133,063 Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027. 23,788 20,853 800,000 Expected dividends 0 % Expected volatility 125.19 % Expected term 6 Risk free interest rate 1.46 % Expected forfeitures 0 % On August 8, 2019, the Company issued a 3-year option to purchase 2,000,000 0.2299 291,842 Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026 51,816 Expected dividends 0 % Expected volatility 105.73 % Expected term 3 Risk free interest rate 1.54 % Expected forfeitures 0 % On August 8, 2019, the Company issued a 2-year options to purchase 125,000 0.2299 Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the year ended December 31, 2020, the Company recorded $ 9,133 12,751 Expected dividends 0 % Expected volatility 105.73 % Expected term 3 Risk free interest rate 1.54 % Expected forfeitures 0 % On August 8, 2019, the Company issued a 2-year options to purchase 125,000 0.2299 19,525 Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the year ended December 31, 2020, the Company recorded $6,520, as an expense for options issued 9,103 Expected dividends 0 % Expected volatility 105.73 % Expected term 3 Risk free interest rate 1.54 % Expected forfeitures 0 % SCHEDULE OF WARRANTS ACTIVITY Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2020 49,120,917 - 1.83 Granted 8,500,000 - - Exercised (2,959,456 ) - - Cancelled/Forfeited (1,250,000 ) - - Balance, September 30, 2021 53,411,461 - 2.65 Intrinsic Value $ 1,741,631 For the nine months ended September 30, 2021, the following warrants were outstanding: SCHEDULE OF WARRANTS OUTSTANDING Exercise Price Warrants Weighted Average Aggregate $ 0.001 11,000,000 3.32 $ 953,500 $ 0.056 1,000,000 3.77 $ 31,500 $ 0.04 2,300,000 5.01 $ 109,250 $ 0.06 4,439,184 0.08 $ 388,428 $ 0.06 7,398,639 0.44 $ 203,463 $ 0.08 3,699,320 0.43 $ 27,745 $ 0.08 3,699,320 1.43 $ 27,745 $ 0.2299 8,250,000 3.46 $ - $ 0.16 3,125,000 4.45 $ - $ 0.25 8,000,000 4.73 $ - $ 0.1160 500,000 3.77 $ - For the year ended December 31, 2020, the following warrants were outstanding: Exercise Price Warrants Weighted Average Remaining Aggregate $ 0.001 11,000,000 1.19 $ 1,371,500 $ 0.056 2,000,000 0.60 $ 139,000 $ 0.04 2,300,000 0.65 $ 196,650 $ 0.06 7,398,639 0.18 $ 484,611 $ 0.06 7,398,639 1.18 $ 484,611 $ 0.08 3,699,320 1.18 $ 168,319 $ 0.08 3,699,320 2.18 $ 168,319 $ 0.2299 8,500,000 4.27 $ - $ 0.16 3,125,000 4.95 $ - For the nine months ended September 30, 2021, the following options were outstanding: SCHEDULE OF OPTIONS OUTSTANDING Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 26,802,500 19.37 For the year ended December 31, 2020, the following options were outstanding: Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 22,267,800 22.6 (D) Amendment to Articles of Incorporation On February 16, 2009, the Company amended its articles of incorporation to amend the number and class of shares the Company is authorized to issue as follows: ● Common stock Class A, unlimited number of shares authorized, no par value ● Common stock Class B, unlimited number of shares authorized, no par value ● Preferred stock, unlimited number of shares authorized, no par value Effective December 17, 2013, the Company amended its articles of incorporation to designate a Series A no par value preferred stock. Two shares of Series A Preferred stock have been authorized. (E) Common Stock Issued for Debt On April 23, 2021, the Company issued 836,574 100,000 1,644 On April 26, 2021, the Company issued 2,063,391 250,000 3,178 On April 30, 2021, the Company issued 2,058,686 250,000 3,630 338,654 On June 7, 2021, the Company issued 2,431,506 200,000 25,644 On June 23, 2021, the Company issued 2,422,195 200,000 10,247 On July 6, 2021, the Company issued 2,343,919 200,000 7,671 On July 20, 2021, the Company issued 1,664,823 100,000 60,822 On July 29, 2021, the Company issued 3,101,546 200,000 11,836 On August 16, 2021, the Company issued 2,277,273 150,000 6,904 On August 23, 2021, the Company issued 3,454,203 200,000 11,397 On August 30, 2021, the Company issued 2,284,808 150,000 3,082 On September 8, 2021, the Company issued 4,311,269 250,000 6,521 On September 14, 2021, the Company issued 2,936,668 200,000 2,630 On September 20, 2021, the Company issued 4,138,369 250,000 4,095

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 9 COMMITMENTS AND CONTINGENCIES On November 10, 2010, the Company entered into an employment agreement with its CEO, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year period 210,000 6 281,027 20 5 297,889 5 315,764 5 398,643 2,918,540 2,804,725 On January 20, 2015, the board of directors appointed Mr. Jonathan R. Rice as our Chief Operating Officer. Mr. Rice’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to an annual cash compensation of $ 120,000 11,000 three-year 2,000,000 0.001 3,000,000 0.001 May 28, 2022 121,448 140,000 three-year 6,000,000 0.001 May 20, 2026 the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the January 2015 warrant to January 10, 2025 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019 6,000,000 0.2299 20,000 20,000 20,000 ● The Company maintaining $ 6,000,000 ● Upon the transfer of ownership of more than 50 ● Upon the fifth year anniversary of the salary increase and the bonus issuance. As of September 30, 2021 and December 31, 2020, the Company owes $ 6,391 103,730 On October 21, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $ 20,000 ● The Company maintaining $ 6,000,000 ● Upon the transfer of ownership of more than 50 ● Upon the fifth year anniversary of the salary increase and the bonus issuance. On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to annual cash compensation of $ 60,000 three-year 2,000,000 0.2299 2,130 888 (A) License Agreement On May 8, 2006, the Company entered into a license agreement. Pursuant to the terms of the agreement, the Company paid a non- refundable license fee of $ 10,000 10,000 13,700 10,000 On October 28, 2011, the Company entered into a license agreement with the University of Notre Dame. Under the agreement, the Company received exclusive and non-exclusive rights to certain spider silk technologies including commercial rights with the right to sublicense such intellectual property. In consideration of the licenses granted under the agreement, the Company agreed to issue to the University of Notre Dame 2,200,000 2 20 The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $ 5,000 4 265,244 4,025,652 281,659 35,000 On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. In accordance with FASB ASC No 480, Distinguishing Liabilities from Equity, 120,000 65,292 490 9,973 On December 30, 2015, the Company entered into a cooperative agreement for the research and pilot production of hybrid silkworms in Vietnam. Under this agreement, the Company will establish a subsidiary in Vietnam where it will develop and produce hybrid silkworms. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. (B) Operating Lease Agreements Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $ 2,508 On May 9, 2019, the Company signed a 5 4,560 45,150 On July 1, 2021, the Company signed a 5 6,000 8,645 On January 23, 2017 the Company signed an 8 960 3,683 6,263 On September 13, 2017, the Company signed a new two year lease with a 2 year option commencing on October 1, 2017 and ending on September 31, 2019. The Company paid an annual rent of $ 39,200 42,000 two-year 42,000 44,800 42,000 44,800

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 10 RELATED PARTY TRANSACTIONS On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. Pursuant to the addendum, the Company agreed to issue either 200,000 voting rights equal to 100 common shares per share of preferred stock Distinguishing Liabilities from Equity 120,000 65,292 7 9,973 On November 10, 2010, the Company entered into an employment agreement, with its CEO, effective January 1, 2011 through the December 31, 2015. Subsequently, on January 1, 2018 the agreement renewed with the same terms for another 5 years with an annual salary of $ 398,643 2,918,540 2,804,725 On January 14, 2016, the Company signed a new employment agreement with Mr. Rice, the Company’s COO. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $ 140,000 three-year 6,000,000 0.001 the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 10, 2025 for Mr. Rice 20,000 20,000 20,000 ● The Company maintaining $ 6,000,000 ● Upon the transfer of ownership of more than 50 ● Upon the fifth year anniversary of the salary increase and the bonus issuance. As of September 30, 2021 and December 31, 2020, the Company owes $ 6,390 103,730 On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to an annual cash compensation of $ 60,000 three-year 2,000,000 0.2299 2,130 888 June 6, 2016, the Company received a $ 50,000 30,000 100,000 15,000 20,000 15,000 15,000 20,000 26,000 11,000 20,000 3,000 30,000 30,000 20,000 20,000 17,000 100,000 100,000 100,000 100,000 100,000 100,000 150,000 100,000 100,000 100,000 30,000 30,000 35,000 70,000 3 1,657,000 1,657,000 1,657,000 61,968 40,138 38,981 24,485 On January 23, 2017, the Company signed an 8 year property lease with the Company’s President for land in Texas. The Company pays $ 960 3,683 6,263 As of September 30, 2021 and December 31, 2020, there was $ 338,049 331,143 As of September 30, 2021, there was $ 1,732,191 108,900 As of December 31, 2020, there was $ 1,562,499 82,238 As of September 30, 2021, the Company owes $ 2,924,436 29,943 3,018 26,110 As of December 31, 2020, the Company owes $ 2,804,725 103,730 888 22,900 The Company owes $ 65,292

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 SUBSEQUENT EVENTS The Company has analyzed its operations subsequent to November 5, 2021 through the date these financial statements were issued, and has determined that, other than disclosed below, it does not have any material subsequent events to disclose. On October 4, 2021, the Company issued 2,957,622 200,000 2,301 On October 12, 2021, the Company issued 4,205,118 250,000 5,671 On October 25, 2021, the Company issued 3,043,955 200,000 1,205 On October 28, 2021, the Company issued a 7-year option to purchase 750,000 shares of common stock at an exercise price of $ 0.0785

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Policies)	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	(A) Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. On March 5, 2018, the Company issued a board resolution authorizing investment in a Vietnamese subsidiary and appointing a representative for the subsidiary. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd.
Foreign Currency	Foreign Currency The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date.
Use of Estimates	Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.
Cash	Cash For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no
Loss Per Share	Loss Per Share Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For September 30, 2021 and December 31, 2020, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive. The computation of basic and diluted loss per share for September 30, 2021 and 2020 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE September 30, 2021 December 31, 2020 Stock Warrants (Exercise price - $ 0.001 0.25 53,411,461 49,120,917 Stock Options (Exercise price - $ 0.1150 26,802,500 27,340,000 Convertible Debt 19,434,477 - Convertible Preferred Stock 2 2 Total 99,648,440 76,460,919
Research and Development Costs	Research and Development Costs The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.
Income Taxes	Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Changes to accounting principles are established by the FASB in the form of ASU’s to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our financial position, results of operations, stockholders’ deficit, cash flows, or presentation thereof. On January 1, 2021, we adopted Accounting Standards Update (ASU) No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (ASU 2020-01), which clarifies the interaction of the accounting for equity securities under Topic 321, the accounting for equity method investments in Topic 323, and the accounting for certain forward contracts and purchased options in Topic 815. The adoption of this new standard did not have a material impact on our condensed consolidated financial statements . In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments, to require financial assets carried at amortized cost to be presented at the net amount expected to be collected based on historical experience, current conditions, and forecasts. Subsequently, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, to clarify that receivables arising from operating leases are within the scope of lease accounting standards. Further, the FASB issued ASU No. 2019-04, ASU No. 2019-05, ASU 2019-10, ASU 2019-11, ASU 2020-02, and ASU 2020-03 to provide additional guidance on the credit losses standard. Adoption of the ASUs is on a modified retrospective basis. We adopted the ASUs on January 1, 2020. The ASUs did not have a material impact on our consolidated financial statements. ASU No. 2016-13 applies to all financial assets including loans, trade receivables and any other financial assets not excluded from the scope that have the contractual right to receive cash. The adoption of this ASU did not have any impact on our financial statements.
Equipment	Equipment The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. In accordance with FASB ASC No. 360, Property, Plant and Equipment, There were no
Fair Value of Financial Instruments	Fair Value of Financial Instruments We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” The three levels of the fair value hierarchy under ASC Topic 820-10 are described below: ● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at September 30, 2021 and 2020. ● Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. ● Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms. SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS September 30, 2021 December 31, 2020 Level 1 – Investment in Gold $ 412,514 $ Level 2 $ - $ - Level 3 $ - $ - Total $ 412,514 $ - The Board of Directors, who serves as the Custodian, is responsible for the safekeeping of gold bullion owned by the Company. Fair value of the gold bullion held by the Company is based on that day’s London Bullion Market Association (“LBMA”) Gold Price PM. “LBMA Gold Price PM” is the price per fine troy ounce of gold, stated in U.S. dollars, determined by ICE Benchmark Administration (“IBA”) following an electronic auction consisting of one or more 30-second rounds starting at 3:00 p.m. (London time), on each day that the London gold market is open for business and published shortly thereafter. SCHEDULE OF GOLD BULLION The following tables summarize activity in gold bullion for the three and nine months ended September 30, 2021: SCHEDULE OF GOLD IN BULLION Three and Nine Months Ended September 30, 2021 Ounces Cost Fair Value Beginning balance - $ - $ - Investment in Gold bullion 239 1,884 450,216 Net change in unrealized depreciation - - (37,702 ) Ending balance 239 $ 1,884 $ 412,514
Revenue Recognition	Revenue Recognition The Company’s revenues have been generated primarily from a contract with the U.S. Government. The Company performed work under a cost-plus-fixed-fee contract. Under the base phase of that contract, the Company produced recombinant spider silk woven into ballistic shootpack panels. Those shootpack panels were delivered to the U.S. Government customer. Under an option period award starting in July 2017 and ending in September 2018, to that original contract, the Company worked to develop new recombinant silks. Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the three and nine months ended September 30, 2021 and 2020, the Company recognized $ 0 0 On January 25, 2021, the Company signed an amendment to a strategic partnership agreement with Kings Group for and exclusive sales agreement for up to $40 million. On April 8, 2021, the Company and Kings Group formed Spydasilk Enterprises Pte. Ltd., a Singapore company, to formalize this partnership.
Concentration of Credit Risk	Concentration of Credit Risk The Company at times has cash in banks in excess of FDIC insurance limits. At September 30, 2021 and December 31, 2020, the Company had approximately $ 2,344,000 500,000 For the nine months ended September 30, 2021 and 2020, the Company booked $0 and $0 for doubtful accounts.
Original Issue Discount	Original Issue Discount For certain notes issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded as a debt discount, reducing the face amount of the note, and is amortized to amortization of original issue discount in the consolidated statements of operations over the life of the debt.
Debt Issue Cost	Debt Issue Cost Debt issuance cost paid to lenders, or third parties are recorded as debt discounts and amortized to interest expense in the consolidated statements of operations, over the life of the underlying debt instrument.
Beneficial Conversion Feature	Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The discount is amortized to interest expense over the life of the debt.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Tables)	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE	The computation of basic and diluted loss per share for September 30, 2021 and 2020 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE September 30, 2021 December 31, 2020 Stock Warrants (Exercise price - $ 0.001 0.25 53,411,461 49,120,917 Stock Options (Exercise price - $ 0.1150 26,802,500 27,340,000 Convertible Debt 19,434,477 - Convertible Preferred Stock 2 2 Total 99,648,440 76,460,919
SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS	SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS September 30, 2021 December 31, 2020 Level 1 – Investment in Gold $ 412,514 $ Level 2 $ - $ - Level 3 $ - $ - Total $ 412,514 $ -
SCHEDULE OF GOLD IN BULLION	SCHEDULE OF GOLD IN BULLION Three and Nine Months Ended September 30, 2021 Ounces Cost Fair Value Beginning balance - $ - $ - Investment in Gold bullion 239 1,884 450,216 Net change in unrealized depreciation - - (37,702 ) Ending balance 239 $ 1,884 $ 412,514

EQUIPMENT (Tables)

EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	At September 30, 2021 and December 31, 2020, property and equipment, net, is as follows: SCHEDULE OF PROPERTY AND EQUIPMENT September 30, 2021 December 31, 2020 Automobile $ 41,805 $ 41,805 Laboratory Equipment 101,656 96,536 Office Equipment 7,260 7,260 Leasehold Improvements 82,742 85,389 Less: Accumulated Depreciation (132,920 ) (141,743 ) Total Property and Equipment, net $ 100,543 $ 89,247

RIGHT TO USE ASSETS AND LEASE_2

RIGHT TO USE ASSETS AND LEASE LIABILITITY (Tables)	9 Months Ended
	Sep. 30, 2021
Right To Use Assets And Lease Liabilitity
SCHEDULE OF RIGHT USE OF ASSETS	Right to use assets is summarized below: SCHEDULE OF RIGHT USE OF ASSETS September 30, 2021 Right to use assets, net 79,862 Right to use assets, net 35,044 Total $ 114,906
SCHEDULE OF LEASE LIABILITY	Lease liability is summarized below: SCHEDULE OF LEASE LIABILITY September 30, 2021 Operating lease liability, net 79,862 Operating lease liability, net 35,044 Total 114,906 Less: short term portion (33,492 ) Long term position $ 81,414
SCHEDULE OF LEASE COST	Lease expense for the nine months ended September 30, 2021 was comprised of the following: SCHEDULE OF LEASE COST Operating lease expense $ 34,786 Operating lease expense $ 53,673 Operating lease expense – related party $ 3,683

CONVERTIBLE NOTES (Tables)

CONVERTIBLE NOTES (Tables)	9 Months Ended
	Sep. 30, 2021
Convertible Notes
SCHEDULE OF FAIR VALUE WARRANTS	SCHEDULE OF FAIR VALUE WARRANTS Stock Price $ 0.14 Exercise price $ 0.16 Expected term (in years) 5 Expected volatility 60.64 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.10 % Stock Price $ 0.15 Exercise price $ 0.25 Expected term (in years) 5 Expected volatility 100.76 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.07 %
SUMMARY OF CONVERTIBLE DEBT	The following represents a summary of the Company’s convertible debt at September 30, 2021: SUMMARY OF CONVERTIBLE DEBT Convertible Note Payable Amounts In-Default Balance – December 31, 2020 50,505 - Proceeds – net 4,000,000 - Debt discount recorded (4,000,000 ) - Conversion of debt into common shares (2,700,000 ) Amortization of debt discount 4,172,955 - Balance – September 30, 2021 $ 1,523,460 $ - Accrued Interest Payable Amounts In-Default Balance – December 31, 2020 5,479 - Interest Expense September 30, 2021 201,507 - Interest conversion into common shares (167,274 ) Balance – September 30, 2021 $ 39,712 $ -

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
SCHEDULE OF OPTION ASSUMPTION	SCHEDULE OF OPTION ASSUMPTION On July 8, 2021, the Company issued a 4-year option to purchase 500,000 0.116 46,890 500,000 Expected dividends 0 % Expected volatility 130.18 % Expected term 4 Risk free interest rate 0.37 % Expected forfeitures 0 % On July 8, 2021, the Company extended the expiration date of the warrant issued on February 9, 2018, to July 8, 2025. During the nine months ended September 30, 2021, the Company recorded an additional $ 100,941 Expected dividends 0 % Expected volatility 130.18 % Expected term 4 Risk free interest rate 0.37 % Expected forfeitures 0 % On April 27, 2021, the Company extended the expiration date of the warrant issued on October 2, 2016 to October 1, 2026. During the nine months ended September 30, 2021 the Company recorded an additional $ 217,715 Expected dividends 0 % Expected volatility 158.54 % Expected term 3 Risk free interest rate 1.37 % Expected forfeitures 0 % On February 2, 2021, the Company extended the expiration date of the warrant to May 29, 2026. During the nine months ended September 30, 2021 the Company recorded an additional $ 85 Expected dividends 0 % Expected volatility 112 % Expected term 5 Risk free interest rate 0.18 % Expected forfeitures 0 % On January 1, 2016, the Company issued 3-year warrant to purchase 6,000,000 0.001 142,526 85 Expected dividends 0 % Expected volatility 112 % Expected term 5 Risk free interest rate 0.18 % Expected forfeitures 0 % On January 25, 2021, the Company issued a 7-year option to purchase 2,500,000 0.134 310,165 Options vest 33.3% on the year one anniversary of the grant date, 33.3% will vest on the second anniversary, and 33.3% will vest on the third year anniversary as long as the employee remains with the Company at the end of each successive year for three years 65,194 Expected dividends 0 % Expected volatility 133.22 % Expected term 7 Risk free interest rate 1.46 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 10-year option to purchase 6,000,000 0.115 626,047 Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030 77,988 Expected dividends 0 % Expected volatility 125.19 % Expected term 3 Risk free interest rate 1.50 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 7-year option to purchase 1,340,000 0.115 133,063 Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027. 23,788 20,853 800,000 Expected dividends 0 % Expected volatility 125.19 % Expected term 6 Risk free interest rate 1.46 % Expected forfeitures 0 % On August 8, 2019, the Company issued a 3-year option to purchase 2,000,000 0.2299 291,842 Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026 51,816 Expected dividends 0 % Expected volatility 105.73 % Expected term 3 Risk free interest rate 1.54 % Expected forfeitures 0 % On August 8, 2019, the Company issued a 2-year options to purchase 125,000 0.2299 Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the year ended December 31, 2020, the Company recorded $ 9,133 12,751 Expected dividends 0 % Expected volatility 105.73 % Expected term 3 Risk free interest rate 1.54 % Expected forfeitures 0 % On August 8, 2019, the Company issued a 2-year options to purchase 125,000 0.2299 19,525 Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the year ended December 31, 2020, the Company recorded $6,520, as an expense for options issued 9,103 Expected dividends 0 % Expected volatility 105.73 % Expected term 3 Risk free interest rate 1.54 % Expected forfeitures 0 %
SCHEDULE OF WARRANTS ACTIVITY	SCHEDULE OF WARRANTS ACTIVITY Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2020 49,120,917 - 1.83 Granted 8,500,000 - - Exercised (2,959,456 ) - - Cancelled/Forfeited (1,250,000 ) - - Balance, September 30, 2021 53,411,461 - 2.65 Intrinsic Value $ 1,741,631
SCHEDULE OF WARRANTS OUTSTANDING	For the nine months ended September 30, 2021, the following warrants were outstanding: SCHEDULE OF WARRANTS OUTSTANDING Exercise Price Warrants Weighted Average Aggregate $ 0.001 11,000,000 3.32 $ 953,500 $ 0.056 1,000,000 3.77 $ 31,500 $ 0.04 2,300,000 5.01 $ 109,250 $ 0.06 4,439,184 0.08 $ 388,428 $ 0.06 7,398,639 0.44 $ 203,463 $ 0.08 3,699,320 0.43 $ 27,745 $ 0.08 3,699,320 1.43 $ 27,745 $ 0.2299 8,250,000 3.46 $ - $ 0.16 3,125,000 4.45 $ - $ 0.25 8,000,000 4.73 $ - $ 0.1160 500,000 3.77 $ - For the year ended December 31, 2020, the following warrants were outstanding: Exercise Price Warrants Weighted Average Remaining Aggregate $ 0.001 11,000,000 1.19 $ 1,371,500 $ 0.056 2,000,000 0.60 $ 139,000 $ 0.04 2,300,000 0.65 $ 196,650 $ 0.06 7,398,639 0.18 $ 484,611 $ 0.06 7,398,639 1.18 $ 484,611 $ 0.08 3,699,320 1.18 $ 168,319 $ 0.08 3,699,320 2.18 $ 168,319 $ 0.2299 8,500,000 4.27 $ - $ 0.16 3,125,000 4.95 $ -
SCHEDULE OF OPTIONS OUTSTANDING	For the nine months ended September 30, 2021, the following options were outstanding: SCHEDULE OF OPTIONS OUTSTANDING Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 26,802,500 19.37 For the year ended December 31, 2020, the following options were outstanding: Weighted Average Exercise Options Options Remaining Price Outstanding Exercisable Contractual Life $ 0.115 - 22,267,800 22.6

SCHEDULE OF ANTIDILUTIVE SECURI

SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE (Details) (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Option exercise price	$ 0.1150	$ 0.1150
Minimum [Member]
Warrant exercise price per share	0.001	0.001
Maximum [Member]
Warrant exercise price per share	$ 0.25	$ 0.25

SCHEDULE OF ANTIDILUTIVE SECU_2

SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE (Details) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	99,648,440	76,460,919
Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	53,411,461	49,120,917
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	26,802,500	27,340,000
Convertible Debt [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	19,434,477
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	2	2

SCHEDULE OF FAIR VALUE OF FINAN

SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities	$ 412,514
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities	412,514
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of assets and liabilities

SCHEDULE OF GOLD IN BULLION (De

SCHEDULE OF GOLD IN BULLION (Details)	9 Months Ended
	Sep. 30, 2021USD ($)oz	Sep. 30, 2020USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Beginning balance, ounce | oz
Beginning balance cost
Beginning balalnce, fair value
Investments in gold bullion, ounce | oz	239
Investments in Gold bullion, cost	$ 1,884
Investment in Gold bullion, fair value	$ 450,216
Gold bullion mass unrealized depreciation, ounce | oz
Net change in unrealized depreciation, cost
Net change in unrealized depreciation, fair value	$ (37,702)
Ending balance, ounce | oz	239
Ending balance, cost	$ 1,884
Ending balance, fair value	$ 412,514

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash equivalents	$ 0		$ 0		$ 0
Impairment losses on equipment			0	$ 0
Revenue
Cash excess of FDIC insurance limits	$ 2,344,000		$ 2,344,000		$ 500,000

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficit	$ 6,342,249
Stockholders' deficiency	5,902,426	$ 6,840,082	$ 5,015,105	$ 6,573,564	$ 6,313,603	$ 5,388,058
Cash used in operating activities	$ 1,405,659	$ 994,557

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Less: Accumulated Depreciation	$ (132,920)	$ (141,743)
Total Property and Equipment, net	100,543	89,247
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	41,805	41,805
Laboratory Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	101,656	96,536
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	7,260	7,260
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 82,742	$ 85,389

EQUIPMENT (Details Narrative)

EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 5,858	$ 8,159	$ 19,304	$ 21,277
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property	$ 49,321	$ 0	$ 49,321	$ 0

SCHEDULE OF RIGHT USE OF ASSETS

SCHEDULE OF RIGHT USE OF ASSETS (Details) - USD ($)	Sep. 30, 2021	Jul. 02, 2021	Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease right-of-use asset, net	$ 114,906	$ 241,800	$ 365,025
Right To Use Assets Net [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease right-of-use asset, net	79,862
Right To Use Assets Net One [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease right-of-use asset, net	$ 35,044

SCHEDULE OF LEASE LIABILITY (De

SCHEDULE OF LEASE LIABILITY (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	$ 114,906
Less: short term portion	(33,492)	$ (124,909)
Long term position	81,414	$ 254,811
Operating Lease Liability Net [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	79,862
Operating Lease Liability Net One [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total	$ 35,044

SCHEDULE OF LEASE COST (Details

SCHEDULE OF LEASE COST (Details)	9 Months Ended
	Sep. 30, 2021USD ($)
Operating Lease Expenses [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease expenses	$ 34,786
Operating Lease Expenses One [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease expenses	53,673
Operating Lease Expenses Related Party [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease expenses	$ 3,683

RIGHT TO USE ASSETS AND LEASE_3

RIGHT TO USE ASSETS AND LEASE LIABILITITY (Details Narrative)	Jul. 02, 2021USD ($)m²	Sep. 05, 2019USD ($)ft²	May 09, 2019USD ($)m²	Jan. 23, 2017USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Apr. 16, 2021USD ($)	Apr. 05, 2021USD ($)	Dec. 31, 2020USD ($)	Sep. 13, 2017USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments				$ 960	$ 3,683	$ 6,263
Right of use assets	$ 241,800				114,906				$ 365,025
Lease liabilities					33,492				$ 124,909
Lease term	5 years	2 years	5 years
Area of land | ft²		5,000
Annual rent, year one		$ 42,000			42,000		$ 42,000			$ 39,200
Annual rent, year two		44,800			44,800		$ 44,800			$ 42,000
Operating Lease, Expense					87,874
Socialist Republic Of Vietnam [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Area of land | m²	6,000		4,560.57
Annual rent, year one	$ 8,645		$ 45,150
Annual rent, year two			$ 45,150
Rent increase percentage			5.00%
Operating Lease Agreements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments		$ 44,800			2,508
Operating Lease Agreements [Member] | Socialist Republic Of Vietnam [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Rent payments	$ 8,645
Area of land | m²	6,000		4,560
Annual rent, year two			$ 45,150
Removal Of New Guidance [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Right of use assets								$ 44,419
Lease liabilities								$ 44,419
Adoption Of New Guidance [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Right of use assets					79,862
Lease liabilities					$ 79,862

ACCRUED INTEREST _ RELATED PA_2

ACCRUED INTEREST – RELATED PARTY (Details Narrative) - USD ($)	Dec. 01, 2020	Nov. 17, 2020	Nov. 04, 2020	Oct. 19, 2020	Sep. 10, 2020	Aug. 12, 2020	Jul. 16, 2020	Jun. 03, 2020	Apr. 08, 2020	Mar. 09, 2020	Jan. 24, 2020	Dec. 18, 2019	Nov. 20, 2019	Mar. 01, 2019	Feb. 19, 2019	Feb. 15, 2019	Feb. 01, 2019	Jan. 17, 2019	Jan. 04, 2019	Dec. 21, 2018	Oct. 12, 2018	Oct. 01, 2018	Jul. 05, 2018	Jun. 29, 2018	Jun. 21, 2018	Apr. 26, 2018	Mar. 31, 2018	Jan. 08, 2018	Dec. 01, 2017	Jun. 06, 2016	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Short-term Debt [Line Items]
Proceeds from debt	$ 70,000	$ 35,000	$ 30,000	$ 30,000	$ 100,000	$ 100,000	$ 100,000	$ 150,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 20,000	$ 100,000	$ 20,000	$ 30,000	$ 30,000	$ 3,000	$ 20,000	$ 11,000	$ 26,000	$ 20,000	$ 15,000	$ 15,000	$ 20,000	$ 15,000	$ 100,000	$ 30,000	$ 50,000
Debt Instrument, Interest rate																																	3.00%
Loans payable amount																															$ 1,657,000		$ 1,657,000
In-kind contribution of interest																															61,968	$ 38,981
Accrued interest																															$ 40,138	$ 24,485
Loan One [Member]
Short-term Debt [Line Items]
Proceeds from debt																			$ 17,000

NOTE PAYABLE (Details Narrative

NOTE PAYABLE (Details Narrative) - USD ($)	Mar. 05, 2021	Apr. 16, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Jul. 08, 2021	Dec. 31, 2020	Mar. 01, 2019
Short-term Debt [Line Items]
Notes payable			$ 115,244		$ 115,244
Debt instrument, interest rate								3.00%
Repayment of debt					35,000	$ 45,000
Debt Instrument, Face Amount							$ 180,244
Forgiven percentage	100.00%
Gain on debt extinguishment (PPP)	$ 90,100				90,100
First Six Months [Member]
Short-term Debt [Line Items]
Repayment of debt					1,000
Seven And Eight Months [Member]
Short-term Debt [Line Items]
Repayment of debt					2,000
Nine Through Twenty Three Months [Member]
Short-term Debt [Line Items]
Repayment of debt					5,000
Twenty Fourth Months [Member]
Short-term Debt [Line Items]
Notes payable			180,224		180,224
13 Months [Member]
Short-term Debt [Line Items]
Repayment of debt					5,000
14 Months [Member]
Short-term Debt [Line Items]
Notes payable			57,622		57,622
20 Months [Member]
Short-term Debt [Line Items]
Notes payable			$ 57,622		$ 57,622
Huntington National Bank [Member]
Short-term Debt [Line Items]
Debt instrument, interest rate		1.00%
Loan		$ 90,100
Debt instrument, maturity date		Apr. 16, 2020
Notre Dame [Member] | Unsecured Promissory Note [Member]
Short-term Debt [Line Items]
Notes payable									$ 265,244
Debt instrument, interest rate									10.00%

SCHEDULE OF FAIR VALUE WARRANTS

SCHEDULE OF FAIR VALUE WARRANTS (Details)	Sep. 30, 2021$ / shares	Dec. 31, 2020
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, term	5 years	5 years
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.14
Measurement Input, Share Price [Member] | Additional Issuance Of Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.15
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.16
Measurement Input, Exercise Price [Member] | Additional Issuance Of Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.25
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, term	5 years
Measurement Input, Expected Term [Member] | Additional Issuance Of Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, term	5 years
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.6064
Measurement Input, Price Volatility [Member] | Additional Issuance Of Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	1.0076
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0
Measurement Input, Expected Dividend Rate [Member] | Additional Issuance Of Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.0010
Measurement Input, Risk Free Interest Rate [Member] | Additional Issuance Of Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.0007

SUMMARY OF CONVERTIBLE DEBT (De

SUMMARY OF CONVERTIBLE DEBT (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Short-term Debt [Line Items]
Balance, beginning	$ 50,505
Proceeds - net	3,670,000
Balance, end	1,523,460
Balance - Accrued Interest Payable	5,479
Balance, In-Default
Interest Expense	201,507
Interest conversion into common shares	(167,274)
Balance - Accrued Interest Payable	39,712
Balance, In-Default
Convertible Notes Payable [Member]
Short-term Debt [Line Items]
Balance, beginning	50,505
Balance, In-Default
Proceeds - net	4,000,000
Debt discount recorded	$ (4,000,000)
Conversion of debt into common shares	(2,700,000)
Amortization of debt discount	$ 4,172,955
Balance, end	1,523,460
Balance, In-Default

CONVERTIBLE NOTES (Details Narr

CONVERTIBLE NOTES (Details Narrative) - USD ($)	Sep. 20, 2021	Sep. 14, 2021	Sep. 08, 2021	Aug. 30, 2021	Aug. 23, 2021	Aug. 16, 2021	Jul. 29, 2021	Jul. 20, 2021	Jul. 06, 2021	Jun. 23, 2021	Jun. 20, 2021	Jun. 07, 2021	Apr. 30, 2021	Apr. 26, 2021	Apr. 23, 2021	Apr. 22, 2021	Apr. 06, 2021	Mar. 25, 2021	Dec. 11, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Debt Instrument [Line Items]
Debt Instrument, interest rate																						3.00%
Proceeds from convertible note payable, net of original issue discount																				$ 3,670,000
Number of warrants issued																				8,000,000		3,125,000
Warrants, term																				5 years		5 years
Fair value of warrants																				$ 3,359,716		$ 2,599,066
Accrued interest																				40,138	$ 24,485
Common Stock [Member]
Debt Instrument [Line Items]
Common shares issued for debt conversion, shares	4,138,369	2,936,668	4,311,269	2,284,808	3,454,203	2,277,273	3,101,546	1,664,823	2,343,919	2,422,195	1,664,823	2,431,506	2,058,686	2,063,391	836,574
Debt conversion, principal value	$ 250,000	$ 200,000	$ 250,000	$ 150,000	$ 200,000	$ 150,000	$ 200,000	$ 100,000	$ 200,000	$ 200,000	$ 100,000	$ 200,000	$ 250,000	$ 250,000	$ 100,000
Accrued interest	$ 4,095	$ 2,630	$ 6,521	$ 3,082	$ 11,397	$ 6,904	$ 11,836	$ 60,822	$ 7,671	$ 10,247	$ 60,822	$ 25,644	$ 3,630	$ 3,178	$ 1,644
Unsecured Convertible Note [Member]
Debt Instrument [Line Items]
Issuance of convertible securities																		$ 4,000,000	$ 1,000,000
Debt instrument, maturity date																			Jan. 11, 2022
Debt Instrument, interest rate																			10.00%
Percentage of original issue discount																			5.00%
Debt instrument, discount																			$ 50,000			1,000,000
Proceeds from convertible note payable, net of original issue discount																			$ 950,000
Debt instrument, description																			The note contains a discount to market feature, whereby, the lender can purchase stock at 90% of the lowest trading price for a period of ten (10) days preceding the conversion date.
Debt issuance costs																				$ 330,000		$ 86,000
Unsecured Convertible Note [Member] | First Convertible Debenture [Member]
Debt Instrument [Line Items]
Issuance of convertible securities																		$ 500,000
Debt instrument, maturity date																		Mar. 25, 2022
Debt Instrument, interest rate																		10.00%
Debt instrument, description																		The note contains a discount to market feature, whereby, the lender can purchase stock at 80% of the lowest trading price for a period of ten (10) days preceding the conversion date.
Unsecured Convertible Note [Member] | Secound Convertible Debenture [Member]
Debt Instrument [Line Items]
Issuance of convertible securities																	$ 500,000
Unsecured Convertible Note [Member] | Third Convertible Debenture [Member]
Debt Instrument [Line Items]
Issuance of convertible securities																$ 3,000,000

SCHEDULE OF OPTION ASSUMPTION (

SCHEDULE OF OPTION ASSUMPTION (Details)	Jul. 08, 2021	Apr. 27, 2021	Feb. 02, 2021	Jan. 25, 2021	Feb. 19, 2020	Aug. 08, 2019	Jan. 02, 2016
Common Stock Warrants And Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends	0.00%	0.00%	0.00%	0.00%	0.00%		0.00%
Expected volatility	130.18%	158.54%	112.00%	133.22%	125.19%		112.00%
Expected term	4 years	3 years	5 years	7 years	3 years		5 years
Risk free interest rate	0.37%	1.37%	0.18%	1.46%	1.50%		0.18%
Expected forfeitures	0.00%	0.00%	0.00%	0.00%	0.00%		0.00%
Common Stock Warrants And Option One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends	0.00%				0.00%
Expected volatility	130.18%				125.19%
Expected term	4 years				6 years
Risk free interest rate	0.37%				1.46%
Expected forfeitures	0.00%				0.00%
Common Stock Warrants And Options [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends						0.00%
Expected volatility						105.73%
Expected term						3 years
Risk free interest rate						1.54%
Expected forfeitures						0.00%
Common Stock Warrants And Options One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends						0.00%
Expected volatility						105.73%
Expected term						3 years
Risk free interest rate						1.54%
Expected forfeitures						0.00%
Common Stock Warrants And Options Two [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividends						0.00%
Expected volatility						105.73%
Expected term						3 years
Risk free interest rate						1.54%
Expected forfeitures						0.00%

SCHEDULE OF WARRANTS ACTIVITY (

SCHEDULE OF WARRANTS ACTIVITY (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Equity [Abstract]
Number of Warrants, Beginning balance	49,120,917
Weighted Average Exercise Price, Beginning balance
Weighted Average Remaining Contractual Life (In Years), Beginning balance	1 year 9 months 29 days
Number of Warrants, Granted	8,500,000
Weighted Average Exercise Price, Granted
Number of Warrants, Exercised	(2,959,456)
Weighted Average Exercise Price, Exercised
Number of Warrants, Cancelled/Forfeited	(1,250,000)
Weighted Average Exercise Price, Cancelled/Forfeited
Number of Warrants, Ending balance	53,411,461	49,120,917
Weighted Average Exercise Price, Intrinsic Value
Weighted Average Remaining Contractual Life (In Years), Ending balance	2 years 7 months 24 days
Number of Warrants, Intrinsic Value	$ 1,741,631

SCHEDULE OF WARRANTS OUTSTANDIN

SCHEDULE OF WARRANTS OUTSTANDING (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Mar. 02, 2021	Mar. 09, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Weighted Average Remaining Contractual Life	1 year 9 months 29 days
Aggregate Intrinsic Value	$ 1,741,631
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.001	$ 0.001	$ 0.06	$ 0.06
Warrants Exercisable	11,000,000	11,000,000
Weighted Average Remaining Contractual Life	3 years 3 months 25 days	1 year 2 months 8 days
Aggregate Intrinsic Value	$ 953,500	$ 1,371,500
Warrant One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.056	$ 0.056	0.06	0.06
Warrants Exercisable	1,000,000	2,000,000
Weighted Average Remaining Contractual Life	3 years 9 months 7 days	7 months 6 days
Aggregate Intrinsic Value	$ 31,500	$ 139,000
Warrant Two [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.04	$ 0.04	0.06	0.08
Warrants Exercisable	2,300,000	2,300,000
Weighted Average Remaining Contractual Life	5 years 3 days	7 months 24 days
Aggregate Intrinsic Value	$ 109,250	$ 196,650
Warrant Three [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.06	$ 0.06	0.06	$ 0.08
Warrants Exercisable	4,439,184	7,398,639
Weighted Average Remaining Contractual Life	29 days	2 months 4 days
Aggregate Intrinsic Value	$ 388,428	$ 484,611
Warrant Four [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.06	$ 0.06	$ 0.06
Warrants Exercisable	7,398,639	7,398,639
Weighted Average Remaining Contractual Life	5 months 8 days	1 year 2 months 4 days
Aggregate Intrinsic Value	$ 203,463	$ 484,611
Warrant Five [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.08	$ 0.08
Warrants Exercisable	3,699,320	3,699,320
Weighted Average Remaining Contractual Life	5 months 4 days	1 year 2 months 4 days
Aggregate Intrinsic Value	$ 27,745	$ 168,319
Warrant Six [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.08	$ 0.08
Warrants Exercisable	3,699,320	3,699,320
Weighted Average Remaining Contractual Life	1 year 5 months 4 days	2 years 2 months 4 days
Aggregate Intrinsic Value	$ 27,745	$ 168,319
Warrant Seven [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.2299	$ 0.2299
Warrants Exercisable	8,250,000	8,500,000
Weighted Average Remaining Contractual Life	3 years 5 months 15 days	4 years 3 months 7 days
Aggregate Intrinsic Value
Warrant Eight [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.16	$ 0.16
Warrants Exercisable	3,125,000	3,125,000
Weighted Average Remaining Contractual Life	4 years 5 months 12 days	4 years 11 months 12 days
Aggregate Intrinsic Value
Warrant Nine [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.25
Warrants Exercisable	8,000,000
Weighted Average Remaining Contractual Life	4 years 8 months 23 days
Aggregate Intrinsic Value
WarrantTen [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price Warrants Outstanding	$ 0.1160
Warrants Exercisable	500,000
Weighted Average Remaining Contractual Life	3 years 9 months 7 days
Aggregate Intrinsic Value

SCHEDULE OF OPTIONS OUTSTANDING

SCHEDULE OF OPTIONS OUTSTANDING (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Equity [Abstract]
Exercise Price	$ 0.115	$ 0.115
Options Outstanding
Options Exercisable	26,802,500	22,267,800
Weighted Average Remaining Contractual Life	19 years 4 months 13 days	22 years 7 months 6 days

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	Sep. 20, 2021	Sep. 14, 2021	Sep. 08, 2021	Sep. 03, 2021	Aug. 30, 2021	Aug. 23, 2021	Aug. 16, 2021	Jul. 29, 2021	Jul. 20, 2021	Jul. 08, 2021	Jul. 06, 2021	Jun. 23, 2021	Jun. 20, 2021	Jun. 07, 2021	Apr. 30, 2021	Apr. 27, 2021	Apr. 26, 2021	Apr. 23, 2021	Mar. 05, 2021	Mar. 04, 2021	Mar. 02, 2021	Feb. 24, 2021	Feb. 02, 2021	Jan. 25, 2021	Jul. 30, 2020	Feb. 19, 2020	Aug. 08, 2019	Mar. 20, 2019	Mar. 09, 2019	Jan. 02, 2016	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	May 04, 2021	Mar. 08, 2019
Class of Stock [Line Items]
Stock issued during period, value																												$ 281,659
Issuance of common stock in connection with cashless exercise																			786,280			70,786			9,941,623						10,000,000	3,816,522	10,000,000
Fair value of warrants																																$ 3,359,716		$ 2,599,066
Option granted, shares										500,000
Debt Instrument, Increase, Accrued Interest																																$ 40,138	$ 24,485
Warrant [Member]
Class of Stock [Line Items]
Warrants to purchase up share																					1,479,728														1,479,728
Warrant exercise price per share																					$ 0.06								$ 0.06			$ 0.001		$ 0.001
Warrant expiration date																					Mar. 8, 2021								Mar. 8, 2021
Stock issued during period, value																				$ 88,784	$ 88,784
Issuance of common stock in connection with cashless exercise																			2,000,000			200,000			10,000,000
Warrant [Member] | Common Stock Exercise Warrant [Member]
Class of Stock [Line Items]
Warrants to purchase up share																					1,479,728														1,479,728
Six Cent Warrant [Member]
Class of Stock [Line Items]
Warrants to purchase up share																																				14,797,278
Warrant exercise price per share																																				$ 0.06
Eight Cent Warrant [Member]
Class of Stock [Line Items]
Warrants to purchase up share																													7,398,639
Warrant exercise price per share																													$ 0.08
Warrant One [Member]
Class of Stock [Line Items]
Warrants to purchase up share																					1,479,728
Warrant exercise price per share																					$ 0.06								$ 0.06			0.056		0.056
Warrant expiration date																					May 8, 2021								Mar. 8, 2022
Warrant Two [Member]
Class of Stock [Line Items]
Warrants to purchase up share																					1,479,728
Warrant exercise price per share																					$ 0.06								$ 0.08			0.04		0.04
Warrant expiration date																					Jul. 8, 2021								Mar. 8, 2022
Warrant Three [Member]
Class of Stock [Line Items]
Warrants to purchase up share																					1,479,728
Warrant exercise price per share																					$ 0.06								$ 0.08			0.06		0.06
Warrant expiration date																					Sep. 8, 2021								Mar. 8, 2023
Warrant Four [Member]
Class of Stock [Line Items]
Warrants to purchase up share																					1,479,727
Warrant exercise price per share																					$ 0.06											$ 0.06		$ 0.06
Warrant expiration date																					Nov. 8, 2021
Common Stock Warrants And Options [Member]
Class of Stock [Line Items]
Number of shares issued																								2,500,000
Share price										$ 0.116														$ 0.134						$ 0.001
Warrants to purchase up share										500,000																				6,000,000
Fair value of warrants										$ 46,890																				$ 142,526
Share based compensation, expense																																$ 100,941
Fair value of options																								$ 310,165
Common stock warrants and options, description																								Options vest 33.3% on the year one anniversary of the grant date, 33.3% will vest on the second anniversary, and 33.3% will vest on the third year anniversary as long as the employee remains with the Company at the end of each successive year for three years
Common Stock Warrants And Options One [Member]
Class of Stock [Line Items]
Share based compensation, expense																$ 217,715
Common Stock Warrants And Options Two [Member]
Class of Stock [Line Items]
Number of shares issued																											2,000,000
Share price																											$ 0.2299
Share based compensation, expense																							$ 85
Fair value of options																											$ 291,842
Options description																											Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026
Common Stock Warrants And Options Three [Member]
Class of Stock [Line Items]
Share based compensation, expense																																85
Common Stock Warrants And Options Four [Member]
Class of Stock [Line Items]
Share based compensation, expense																																65,194
Common Stock Warrants And Option One [Member]
Class of Stock [Line Items]
Number of shares issued																										6,000,000
Share price																										$ 0.115
Fair value of options																										$ 626,047
Options description																										Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030
Common Stock Warrants And Options Five [Member]
Class of Stock [Line Items]
Share based compensation, expense																																77,988
Common Stock Warrants And Option Two [Member]
Class of Stock [Line Items]
Number of shares issued																										1,340,000
Share price																										$ 0.115
Fair value of options																										$ 133,063
Options description																										Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027.
Options, cancelled, Intrinsic Value																																$ 20,853
Options expirations in Period, shares																																800,000
Common Stock Warrants And Options Six [Member]
Class of Stock [Line Items]
Share based compensation, expense																																$ 23,788
Common Stock Warrants And Options Seven [Member]
Class of Stock [Line Items]
Number of shares issued																											125,000
Share price																											$ 0.2299
Share based compensation, expense																																$ 51,816		$ 9,133
Options description																											Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the year ended December 31, 2020, the Company recorded $9,133, as an expense for options issued
Warrant Expense																					$ 12,751
Common Stock Warrants And Options Eight [Member]
Class of Stock [Line Items]
Number of shares issued																											125,000
Share price																											$ 0.2299
Fair value of warrants																											$ 19,525
Options description																											Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the year ended December 31, 2020, the Company recorded $6,520, as an expense for options issued
Warrant Expense																					$ 9,103
Common Stock [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	4,138,369	2,936,668	4,311,269		2,284,808	3,454,203	2,277,273	3,101,546	1,664,823		2,343,919	2,422,195	1,664,823	2,431,506	2,058,686		2,063,391	836,574
Debt Conversion, Converted Instrument, Amount	$ 250,000	$ 200,000	$ 250,000		$ 150,000	$ 200,000	$ 150,000	$ 200,000	$ 100,000		$ 200,000	$ 200,000	$ 100,000	$ 200,000	$ 250,000		$ 250,000	$ 100,000
Debt Instrument, Increase, Accrued Interest	$ 4,095	$ 2,630	$ 6,521		$ 3,082	$ 11,397	$ 6,904	$ 11,836	$ 60,822		$ 7,671	$ 10,247	$ 60,822	$ 25,644	3,630		$ 3,178	$ 1,644
[custom:FairValueOfIssuedShares]															$ 338,654
Common Class A [Member]
Class of Stock [Line Items]
Number of shares issued				3,000,000
Stock issued during period, value				$ 242,100
Common Class A [Member] | Warrant [Member]
Class of Stock [Line Items]
Warrants to purchase up share																																				14,797,278
Common Class B [Member]
Class of Stock [Line Items]
Share price				$ 0.0807
Purchase Agreement [Member] | Investor [Member]
Class of Stock [Line Items]
Number of shares issued																													14,797,278
Share price																													$ 0.06758
Proceeds from issuance of common stock																													$ 1,000,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)

Oct. 25, 2021shares

Oct. 12, 2021shares

Oct. 04, 2021shares

Sep. 03, 2021USD ($)shares

Jul. 02, 2021USD ($)m²

Oct. 21, 2019USD ($)

Sep. 05, 2019USD ($)ft²

Aug. 15, 2019USD ($)

Aug. 15, 2019USD ($)

Jul. 03, 2019USD ($)$ / sharesshares

May 09, 2019USD ($)m²

Apr. 26, 2019USD ($)

Mar. 20, 2019USD ($)

Jan. 31, 2019USD ($)shares

Jan. 09, 2018

Jan. 23, 2017USD ($)

Jan. 14, 2016$ / sharesshares

Jan. 14, 2016USD ($)$ / sharesshares

May 28, 2015$ / sharesshares

Jan. 20, 2015USD ($)$ / sharesshares

Oct. 28, 2011shares

Nov. 10, 2010USD ($)

Dec. 26, 2006USD ($)shares

May 08, 2006USD ($)

Jan. 31, 2007USD ($)

Sep. 30, 2021USD ($)$ / shares

Sep. 30, 2020USD ($)

Sep. 30, 2021USD ($)$ / shares

Sep. 30, 2020USD ($)

Dec. 31, 2021USD ($)

Dec. 31, 2017

Dec. 31, 2017USD ($)

Dec. 31, 2016USD ($)

Dec. 31, 2015USD ($)

Oct. 28, 2021USD ($)

Jul. 08, 2021USD ($)

Apr. 16, 2021USD ($)

Dec. 31, 2020USD ($)$ / shares

Aug. 08, 2019$ / sharesshares

Jul. 02, 2019

Mar. 20, 2018

Sep. 13, 2017USD ($)

Loss Contingencies [Line Items]

Annual salary

$ 162,498

$ 161,861

$ 494,090

$ 361,276

Accrued salary balance

$ 2,918,540

$ 2,918,540

$ 2,804,725

License termination fee

$ 5,000

Warrants term

5 years

5 years

5 years

Payment for debt

$ 35,000

45,000

Stock issued during period, value

$ 281,659

Outstanding balance

$ 180,244

Interest and Debt Expense

490

Accrued Interest payable

$ 39,712

39,712

$ 5,479

Payments for rent

$ 960

3,683

$ 6,263

Area of land | ft²

5,000

Annual rent, year two

$ 44,800

44,800

44,800

$ 44,800

$ 42,000

Annual rent, year one

42,000

$ 42,000

$ 42,000

$ 42,000

$ 39,200

Socialist Republic Of Vietnam [Member]

Loss Contingencies [Line Items]

Area of land | m²

6,000

4,560.57

Annual rent, year two

$ 45,150

Annual rent, year one

$ 8,645

$ 45,150

Maximum [Member]

Loss Contingencies [Line Items]

Warrant exercise price per share | $ / shares

$ 0.25

$ 0.25

$ 0.25

Common Class A [Member]

Loss Contingencies [Line Items]

Number of shares issued | shares

3,000,000

Stock issued during period, value

$ 242,100

Subsequent Event [Member]

Loss Contingencies [Line Items]

Number of shares issued | shares

3,043,955

4,205,118

2,957,622

Mr. Jonathan R. Rice [Member]

Loss Contingencies [Line Items]

Payroll payment

$ 6,390

$ 6,390

$ 103,730

Mr Rice [Member]

Loss Contingencies [Line Items]

Payroll payment

6,391

6,391

103,730

Mr. Kenneth Le [Member]

Loss Contingencies [Line Items]

Accrued salary balance

2,130

2,130

888

Board of Directors Chairman [Member]

Loss Contingencies [Line Items]

Accrued salary balance

2,130

$ 2,130

888

Employment Agreement [Member]

Loss Contingencies [Line Items]

Extended expiration date description

the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 10, 2025 for Mr. Rice

Employment Agreement [Member] | Chief Executive Officer [Member]

Loss Contingencies [Line Items]

Agreement term description

The term of the agreement is a five year period

Annual salary

$ 210,000

$ 315,764

$ 297,889

$ 281,027

Annual salary rate, increase

6.00%

Agreement term

5 years

5 years

5 years

Employment Agreement [Member] | Chief Executive Officer [Member] | Subsequent Event [Member]

Loss Contingencies [Line Items]

Annual salary

$ 398,643

Employment Agreement [Member] | Employee [Member]

Loss Contingencies [Line Items]

Employee bonus rate

20.00%

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member]

Loss Contingencies [Line Items]

Annual salary

$ 20,000

$ 20,000

$ 20,000

Annual cash compensation

$ 140,000

$ 120,000

Educational expenses

$ 11,000

Warrants term, description

three-year

Warrant to purchase common stock shares | shares

6,000,000

6,000,000

6,000,000

Warrant exercise price per share | $ / shares

$ 0.001

$ 0.001

$ 0.2299

Warrants maturity date

May 20, 2026

May 20, 2026

Warrants issued value

$ 121,448

Extended expiration date description

the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the January 2015 warrant to January 10, 2025 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019

One-time bonus

$ 20,000

Working capital

$ 6,000,000

$ 6,000,000

$ 6,000,000

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member] | Ownership [Member]

Loss Contingencies [Line Items]

Ownership percentage

50.00%

50.00%

50.00%

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member] | May 2015 Warrant [Member]

Loss Contingencies [Line Items]

Warrants term, description

three-year

Warrant to purchase common stock shares | shares

3,000,000

Warrant exercise price per share | $ / shares

$ 0.001

Warrants maturity date

May 28, 2022

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member] | January 2015 Warrant [Member]

Loss Contingencies [Line Items]

Warrant to purchase common stock shares | shares

2,000,000

Warrant exercise price per share | $ / shares

$ 0.001

Employment Agreement [Member] | Mr. Kenneth Le [Member]

Loss Contingencies [Line Items]

Accrued salary balance

3,018

$ 3,018

Annual cash compensation

$ 60,000

Warrants term, description

three-year

Warrant to purchase common stock shares | shares

2,000,000

Warrant exercise price per share | $ / shares

$ 0.2299

Salary Increment [Member] | Mr Rice [Member]

Loss Contingencies [Line Items]

Annual salary

$ 20,000

License Agreement [Member]

Loss Contingencies [Line Items]

Agreement term

20 years

License fee

$ 10,000

License maintenance fee

$ 10,000

Annual research fee

$ 13,700

Number of shares issued | shares

2,200,000

Royalty percentage

2.00%

Termination agreement description

The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years

Accrued Interest payable

9,973

9,973

Payments for rent

3,683

License Agreement [Member] | Monthly Rent [Member]

Loss Contingencies [Line Items]

Payments for rent

960

License Agreement [Member] | Maximum [Member]

Loss Contingencies [Line Items]

Annual research fee

$ 10,000

License Agreement [Member] | Common Class A [Member]

Loss Contingencies [Line Items]

Number of shares issued | shares

4,025,652

Payment for debt

$ 265,244

Consulting Agreement [Member] | Consultant [Member]

Loss Contingencies [Line Items]

Warrants term

4 years

Royalty and Research Agreements [Member] | Mr. Thompson [Member]

Loss Contingencies [Line Items]

Payment for debt

$ 120,000

Intellectual Property Transfer Agreement [Member] | Mr. Thompson [Member]

Loss Contingencies [Line Items]

Number of shares issued | shares

200,000

Stock issued during period, value

$ 120,000

Outstanding balance

$ 65,292

65,292

$ 65,292

Operating Lease Agreements [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 44,800

2,508

Operating lease, term

8 years

Operating lease term, description

two-year

Operating Lease Agreements [Member] | October 1, 2022 through September 30, 2023 [Member]

Loss Contingencies [Line Items]

Payments for rent

44,800

Operating Lease Agreements [Member] | Office and Manufacturing Space [Member] | July One Two Thousand Twenty One And September Thrity Two Thousand Twenty Two [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 42,000

Operating Lease Agreements [Member] | Socialist Republic Of Vietnam [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 8,645

Operating lease description

the Company signed a 5 year property lease with the Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five

Operating lease, term

5 years

5 years

Area of land | m²

6,000

4,560

Annual rent, year two

$ 45,150

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Oct. 25, 2021	Oct. 12, 2021	Oct. 04, 2021	Dec. 01, 2020	Nov. 17, 2020	Nov. 04, 2020	Oct. 19, 2020	Sep. 10, 2020	Aug. 12, 2020	Jul. 16, 2020	Jun. 03, 2020	Apr. 08, 2020	Mar. 09, 2020	Feb. 19, 2020	Jan. 24, 2020	Dec. 18, 2019	Nov. 20, 2019	Sep. 05, 2019	Aug. 15, 2019	Aug. 15, 2019	Jul. 03, 2019	Apr. 26, 2019	Mar. 20, 2019	Mar. 01, 2019	Feb. 15, 2019	Feb. 01, 2019	Jan. 17, 2019	Jan. 04, 2019	Jan. 04, 2019	Dec. 21, 2018	Oct. 12, 2018	Oct. 01, 2018	Jun. 29, 2018	Jun. 21, 2018	Jun. 05, 2018	Apr. 26, 2018	Mar. 31, 2018	Jan. 09, 2018	Jan. 08, 2018	Dec. 02, 2017	Jan. 23, 2017	Jun. 06, 2016	Jan. 14, 2016	Jan. 14, 2016	Jan. 20, 2015	Nov. 10, 2010	Dec. 26, 2006	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jul. 08, 2021	Oct. 21, 2019	Aug. 08, 2019
Related Party Transaction [Line Items]
Stock issued during period, value																							$ 281,659
Outstanding balance																																																									$ 180,244
Debt Instrument, interest rate																																																					3.00%
Annual salary																																																$ 162,498	$ 161,861	$ 494,090	$ 361,276
Accrued salary balance																																																2,918,540		2,918,540			$ 2,804,725
Paid-in-Kind Interest																																																		61,968	38,981
Debt Instrument, Increase, Accrued Interest																																																		40,138	24,485
Payments for rent																																									$ 960									3,683	6,263
Loan interest - related party																																																108,900		108,900
Related Party [Member]
Related Party Transaction [Line Items]
Accrued interest																																																1,732,191		1,732,191			1,562,499
Payments for rent																																																		3,683	$ 6,263
Loan interest - related party																																																					82,238
Royalty payable to related party																																																		65,292			65,292
Subsequent Event [Member]
Related Party Transaction [Line Items]
Number of shares issued	3,043,955	4,205,118	2,957,622
Accrued interest	$ 1,205	$ 5,671	$ 2,301
Mr. Jonathan R. Rice [Member]
Related Party Transaction [Line Items]
Payroll payable																																																6,390		6,390			103,730
Mr. Kenneth Le [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																																2,130		2,130			$ 888
Stockholder [Member]
Related Party Transaction [Line Items]
Debt Instrument, interest rate																																																					3.00%
Loan received				$ 70,000	$ 35,000	$ 30,000	$ 30,000	$ 100,000	$ 100,000	$ 100,000	$ 150,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000							$ 20,000	$ 20,000	$ 30,000	$ 30,000	$ 17,000	$ 3,000	$ 20,000	$ 11,000	$ 26,000	$ 15,000	$ 15,000	$ 20,000	$ 20,000	$ 15,000		$ 100,000	$ 30,000		$ 50,000
Loans payable																																																1,657,000		1,657,000			$ 1,657,000
Chief Executive Officer And Chief Operations Officer [Member]
Related Party Transaction [Line Items]
Accounts payable and accrued expenses																																																338,049		338,049			331,143
Principal Stockholder [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																																2,924,436		2,924,436			2,804,725
Director And Employee [Member]
Related Party Transaction [Line Items]
Payroll payable																																																29,943		29,943			103,730
Office Employee [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																																26,110		26,110			22,900
Intellectual Property Transfer Agreement [Member] | Mr. Thompson [Member]
Related Party Transaction [Line Items]
Number of shares issued																																															200,000
Preferred stock voting rights																																															voting rights equal to 100 common shares per share of preferred stock
Stock issued during period, value																																															$ 120,000
Outstanding balance																																																$ 65,292		$ 65,292			$ 65,292
Debt Instrument, interest rate																																																7.00%		7.00%
Accrued interest																																																$ 9,973		$ 9,973
Employment Agreement [Member]
Related Party Transaction [Line Items]
Extended expiration date description																																						the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 10, 2025 for Mr. Rice
Employment Agreement [Member] | Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Annual salary																																														$ 210,000								$ 315,764	$ 297,889	$ 281,027
Employment Agreement [Member] | Chief Executive Officer [Member] | Subsequent Event [Member]
Related Party Transaction [Line Items]
Annual salary																																																				$ 398,643
Employment Agreement [Member] | Mr. Jonathan R. Rice [Member]
Related Party Transaction [Line Items]
Annual salary																			$ 20,000	$ 20,000		$ 20,000
Annual cash compensation																																												$ 140,000	$ 120,000
Warrants term, description																																											three-year
Warrant to purchase shares																																											6,000,000	6,000,000															6,000,000
Warrant exercise price per share																																											$ 0.001	$ 0.001															$ 0.2299
Extended expiration date description																																						the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the January 2015 warrant to January 10, 2025 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019
One-time bonus																						$ 20,000
Working capital																			$ 6,000,000	$ 6,000,000																																						$ 6,000,000
Employment Agreement [Member] | Mr. Jonathan R. Rice [Member] | Ownership [Member]
Related Party Transaction [Line Items]
Ownership percentage																			50.00%	50.00%																																						50.00%
Employment Agreement [Member] | Mr. Kenneth Le [Member]
Related Party Transaction [Line Items]
Accrued salary balance																																																$ 3,018		3,018
Annual cash compensation																					$ 60,000
Warrants term, description																					three-year
Warrant to purchase shares																					2,000,000
Warrant exercise price per share																					$ 0.2299
Operating Lease Agreements [Member]
Related Party Transaction [Line Items]
Payments for rent																		$ 44,800																																$ 2,508
Operating Lease Agreements [Member] | President [Member]
Related Party Transaction [Line Items]
Payments for rent																																									$ 960

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)	Oct. 28, 2021	Oct. 25, 2021	Oct. 12, 2021	Oct. 04, 2021
Subsequent Event [Line Items]
Stock issued during period, shares		3,043,955	4,205,118	2,957,622
Debt conversion, value		$ 200,000	$ 250,000	$ 200,000
Interest Payable		$ 1,205	$ 5,671	$ 2,301
Common Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Acquisitions	750,000
Exercise price of common stock	$ 0.0785